PTLF (Petlife Pharmaceuticals) Cyclically Adjusted PS Ratio: (As of Aug. 16, 2026)

Petlife Pharmaceuticals  (OTCPK:PTLF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Petlife Pharmaceuticals Cyclically Adjusted PS Ratio Related Terms

The historical data trend for Petlife Pharmaceuticals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Cyclically Adjusted PS Ratio Chart

Petlife Pharmaceuticals Annual Data
	Trend	Aug08	Aug09	Aug10	Aug11	Aug12	Aug13	Aug14	Aug15	Aug16	Aug17
Cyclically Adjusted PS Ratio		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

Petlife Pharmaceuticals Quarterly Data
	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Aug16	Nov16	Feb17	May17	Aug17	Nov17	Feb18
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PTLF vs PCYN, YBAO, BKIT: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Petlife Pharmaceuticals Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.

Petlife Pharmaceuticals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Petlife Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2018 is calculated as:

For example, Petlife Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Feb. 2018 was:

Current CPI (Feb. 2018) = 248.9910.

Petlife Pharmaceuticals Quarterly Data

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Petlife Pharmaceuticals Business Description